Variables | Control (n=49) | RIF (n=56) | P-value |
---|---|---|---|
Age (yr.) | 28.67 ± 4.02 | 30.01 ± 4.14 | 0.09 |
AMH (ng/ml)a | 6.70 (5.59) | 3.1 (2.53) | 0.06 |
Cycle daya | 17.00 (1.00) | 18.00 (2.00) | 0.44 |
Gonadotropin dose (IU)a | 1500.00 (825.00) | 1350.00 (768.75) | 0.95 |
Duration of infertility (yr.) | 8.04 ± 4.03 | 9.01 ± 4.27 | 0.23 |
Protocols | |||
 Agonist | 5 (10.2) | 9 (16.1) | 0.67 |
 Antagonist | 40 (81.6) | 43 (76.8) | |
 Micro dose | 4 (8.2) | 4 (7.1) | |
Trigger | |||
 HCG | 24 (49) | 32 (57.1) | 0.69 |
 Agonist | 15 (30.6) | 15 (26.8) | |
 Double | 10 (20.4) | 9 (16.1) | |
Number of ET | |||
 1 | 3 (6.1) | 10 (17.9) | 0.18 |
 2 | 35 (71.4) | 36 (64.3) | |
 3 | 11 (22.4) | 10 (17.9) | |
Indications for IVF treatment | |||
 Male factor | 19 (38.8) | 24 (42.9) | 0.81 |
 Female factor | 18 (36.7) | 16 (28.6) | |
 Unexplained factor | 3 (6.1) | 5 (8.9) | |
 Male and female factors | 9 (18.4) | 11 (19.6) | |
Type of infertility | |||
 Primary | 42 (85.7) | 51 (91.1) | 0.54 |
 Secondary | 7 (14.3) | 5 (8.9) |